查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198725

血管移植物市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Vascular Graft Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2022 年至 2027 年），血管移植物市場的複合年增長率預計為 5.7%。

由於運營、供應鏈、分銷系統等方面的中斷，COVID-19 爆發對血管移植物市場產生了不利影響。 此外，許多擇期手術已被取消或推遲，以遏制冠狀病毒的傳播。 例如，根據 2020 年 5 月在英國外科雜誌上發表的一項研究“因 COVID-19 大流行而取消選擇性手術：全球預測模型為手術恢復計劃提供信息”，COVID 導致醫院服務中斷的高峰期-19以12週時間計算，2020年全球約有2840萬例擇期手術被取消或推遲。 這些研究表明，COVID-19感染在預測期內對血管移植市場產生了重大影響。

推動市場增長的主要因素包括透析程序的增加和全球慢性腎病 (CKD) 患者的增加。 據國家腎臟基金會稱，2020 年將有超過 200 萬人接受透析治療。 在美國，腎臟疾病估計影響了 3700 萬人（佔成年人口的 15%，或超過七分之一的成年人）。 此外，心血管疾病、糖尿病和終末期腎病的流行也有望推動市場。 心血管疾病（CVD）是美國主要的死亡原因之一，根據世界衛生組織2020年發布的數據，2019年估計有1790萬人死於CVD。

此外，根據國際腎髒病學會（ISN）和國際腎臟基金會聯合會（IFKF）聯合舉辦的“世界腎臟日”公佈的數據，2020年，約有8.5億人受到影響由腎臟疾病。 據估計，每 10 個成年人中就有 1 個患有慢性腎病 (CKD)。 CKD 的全球負擔持續增加，預計到 2040 年將成為全球損失生命年的第五大原因。

血管移植物的廣泛使用，例如電紡聚氨酯血管移植物用於復雜的血管創傷（因為它們可以降低新內膜形成的風險）預計將在預測期內推動市場。

此外，專注於推出創新產品的市場參與者正在推動市場的增長。 例如，2021 年 9 月，Terumo Aortic 開始探索 PANTHER 針織和機織外科移植物的世界。 主要參與者為擴大和加強市場而採取的併購、合作和夥伴關係等戰略也將推動增長。

除上述因素外，遺傳和遺傳因素、不健康的生活方式、飲酒和吸煙預計都會增加對血管移植物的需求。 在新興國家，低報銷率和不斷上升的自付費用可能會限制市場增長。

血管移植物市場趨勢

腎功能衰竭部分預計在預測期內增長

由於患有腎病、終末期腎病的患者數量不斷增加以及移植物的可用性，預計腎衰竭部分在預測期內增長最快。 腎衰竭的治療方法是用腎移植代替腎臟。 在此過程中使用血管移植物。 腎移植使用血管移植物來重建腎臟的血管。

例如，在國際腎髒病學會（ISN）和國際腎臟基金會聯合會（IFKF）於2020年3月聯合舉辦的“世界腎臟日”上，目前全球約有8.5億人患有腎臟疾病。據稱受苦，預計到 2040 年將成為全球損失歲月的第五大原因。 此外，2020年，腎臟基金會發布的一份報告發現，加拿大約有400萬人患有腎臟疾病，其中46%的新病例年齡在65歲以下。 此外，根據同一消息來源，自 2009 年以來，患有終末期腎病的人數增加了 35%。 因此，由於慢性腎髒病患病率上升，預計市場在預測期內將出現高速增長。

此外，2022 年 5 月，加州再生醫學研究所 (CIRM) 要求加州大學戴維斯分校的王愛軍教授為治療腎衰竭的血液透析患者開發一種智能、耐用的血管裝置。授予 300 萬美元的資助，用於 該裝置使用一種獨特的分子來引導體內的干細胞，以幫助防止合成血管移植物的失敗。 同樣在 2021 年 7 月，Vascudyne 首次將其 TRUE 血管移植物用於需要血液透析通路的終末期腎病患者。

因此，預計終末期腎病發病率的增加將增加對血管移植物的需求，並有助於市場增長。

預計在預測期內北美將佔據最大的市場份額

北美主導著血管移植物市場。 北美由於糖尿病、心血管疾病和慢性腎病的高患病率而保持主導地位。 報銷計劃的存在和最先進的醫療保健基礎設施的可用性正在推動北美這個市場的增長。

根據 2020 年心髒病和中風統計情況說明書，預計美國每年至少有 40,000 名嬰兒會受到先天性心髒病的影響。 這些嬰兒中約有 25%（每 1,000 名活產嬰兒中有 2.4 名）在出生後的第一年內需要接受治療。 根據美國疾病控制和預防中心 (CDC) 的數據，到 2030 年，美國房顫的患病率估計將增加到 1210 萬。 心髒病患病率的上升預計將在未來幾年推動血管移植市場的增長。

此外，根據美國國家糖尿病、胃腸病學和腎臟疾病研究所的數據，到 2021 年，慢性腎病將影響美國超過七分之一的成年人，估計有 3700 萬美國人。據說 隨著慢性腎病患者數量的增加，對血管移植物的需求也在增加。 預計這將在預測期內推動該地區的市場增長。

此外，新產品在市場上的推出和批准將推動市場的持續增長達到新的高度。 例如，2020 年 9 月，Terumo Aortic 在美國推出了 Treo 腹部覆膜支架系統。 此外，2021 年 3 月，Vascular Grafts Solutions (VGS) Ltd. 獲得了美國食品和藥物管理局 (USFDA) 的上市許可，用於冠狀動脈旁路移植術 (CABG) 中的新型無夾鉗近端吻合裝置 VIOLA。我得到了

因此，由於上述因素，預計北美地區在預測期內將出現顯著增長。

血管移植市場競爭對手分析

血管移植市場競爭激烈，由幾家大型企業組成。 這些主要參與者中的大多數都在全球開展業務，並在新興市場面臨激烈的競爭。 市場上的主要參與者包括雅培實驗室、B. Braun Melsungen AG、Bard Peripheral Vascular Inc (BD)、Cardinal Health (Cordis)、Cook Medical、Cryolife、Getinge Group、LeMaitre Vascular Inc、Medtronic plc、Terumo Medical Corporation、W.L. Includes許多參與者，例如 Gore & Associates Inc.

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 改善生活方式相關疾病的患病率
    • 血管移植支架材料和設計的技術進步
  • 市場製約因素
    • 不利的贖回情景
    • 與移植失敗相關的高風險
  • 五力分析分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 血液透析通路移植物
    • 血管內覆膜支架
    • 外周血管移植
    • 冠狀動脈旁路移植術
  • 通過使用
    • 動脈瘤
    • 腎功能衰竭
    • 血管阻塞
    • 冠狀動脈疾病
    • 其他用途
  • 按原材料
    • 合成材料
    • 生物原料
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company（Bard Peripheral Vascular Inc.）
    • Cardinal Health（Cordis Corporation）
    • Cook Medical
    • Cryolife
    • Getinge Group
    • LeMaitre Vascular Inc
    • Medtronic PLC
    • Terumo Medical Corporation
    • W.L. Gore & Associates Inc
    • Endologix Inc.
    • Vascular Graft Solution Ltd.
    • OrbusNeich

第7章 市場機會與今後動向

簡介目錄
Product Code: 62301

The vascular graft market is projected to register a CAGR of 5.7% during the forecast period (2022 - 2027).

The outbreak of COVID-19 had a negative impact on the vascular grafts market due to the disruption in operations, supply chains, distribution systems, etc. Also, many elective procedures were canceled or postponed to control the spread of coronavirus. For instance, according to the study published in the British Journal of Surgery in May 2020, "Elective surgery cancellations due to the COVID-19 pandemic: global predictive modeling to inform surgical recovery plans" based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. Such studies show that the COVID-19 infection has significantly impacted the vascular graft market over the forecast period.

Key factors driving the market growth include the increasing number of dialysis procedures and rising chronic kidney disease (CKD) cases globally. According to the National Kidney Foundation, in 2020, over 2 million people received treatment for dialysis. Kidney disease affects an estimated 37 million people in the United States (15% of the adult population; more than 1 in 7 adults). Moreover, the prevalence of cardiovascular diseases, diabetes, and end-stage renal disease is also expected to drive the market. Cardiovascular disease (CVD) is one of the leading causes of death in the United States, and according to the data published by World Health Organization in 2020, an estimated 17.9 million people died due to CVD in 2019.

Moreover, in 2020, as per data released on World Kidney Day, a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), kidney disease affected around 850 million people globally. As per estimates, one in ten adults has chronic kidney disease (CKD). The global burden of CKD is continuously increasing and is projected to become the 5th most common cause of years of life lost globally by 2040.

The extensive use of prosthetic grafts such as electrospun polyurethane vascular grafts for complex vascular trauma (as it reduces the risk of neointimal formation) is expected to propel the market over the forecast period.

Furthermore, the market players focusing on introducing innovative products are fueling the market growth. For instance, in September 2021, Terumo Aortic launched PANTHER - a global surgical graft study of knitted and woven surgical grafts. Also, strategies such as mergers & acquisitions, collaborations, and partnerships adopted by key players to expand and strengthen the market propel the growth.

Besides the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, and tobacco smoking, among others, are expected to increase the demand for vascular grafts. A low reimbursement rate and rising out-of-pocket expenses in emerging economies can restrain the market growth.

Vascular Graft Market Trends

Kidney Failure Segment is Expected to Witness Growth Over the Forecast Period

The kidney failure segment is expected to witness the fastest growth during the forecast period owing to the increasing number of patients with kidney diseases, end-stage kidney failure, and the availability of procedures using grafts. Kidney Failure is treated by replacing a kidney through a kidney transplant. This process uses vascular grafts. The renal vessel is reconstructed in kidney transplantation using vascular grafts.

For instance, on World Kidney Day, a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF) in March 2020, it was stated that currently, around 850 million people globally suffer from a kidney disorder, and it is expected to become the 5th most common cause of years of life lost globally by 2040. Additionally, in 2020, a report published by Kidney Foundation stated that around 4 million people have kidney disease in Canada, of which 46% of new patients are under 65. Moreover, as per the same source, the number of people living with end-stage kidney disease has grown by 35% since 2009. Hence, owing to the rising prevalence of chronic kidney diseases, the market is expected to witness high growth over the forecast period.

Furthermore, in May 2022, the California Institute for Regenerative Medicine (CIRM) awarded UC Davis Professor Aijun Wang a USD 3 million grant to develop a smart, durable vascular device for hemodialysis patients treated for kidney failure. This device uses a unique molecule that guides the body's stem cells to help prevent the failure of synthetic vascular grafts. Also, in July 2021, Vascudyne used its TRUE Vascular Graft in end-stage renal disease patients requiring hemodialysis access first time on a human.

Hence, the increasing incidence of end-stage kidney failure is expected to increase the demand for vascular grafts, which will also help the market's growth.

North America is Expected to Retain Largest Market Share Over the Forecast Period

North America dominates the vascular graft market. North America maintained its dominant share due to the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. The presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America.

Heart Disease & Stroke Statistical Fact Sheet 2020 estimates that a minimum of 40,000 infants are expected to be affected yearly by congenital heart defects in the United States. About 25% or 2.4 (per 1,000 live births) of these infants require treatment in the first year of life. In addition, according to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030. The rise in the prevalence of cardiac diseases is expected to boost the vascular graft market growth in the coming years.

Moreover, as per the National Institute of Diabetes and Digestive and Kidney Diseases, in 2021, Chronic Kidney Disease affected more than 1 in 7 US adults, an estimated 37 million Americans. With the increase in chronic kidney disease cases, there is a need for vascular grafts. This is expected to enhance the market growth in the region during the forecast period.

Also, new product launches and approval in the market will push the market to continue to grow to new heights. For instance, in September 2020, Terumo Aortic Launched Treo Abdominal Stent Graft System in the United States. Moreover, in March 2021, Vascular Grafts Solutions (VGS) Ltd. received marketing clearance from the United States Food and Drug Administration (USFDA) for the VIOLA, a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG).

Thus, owing to the abovementioned factors, the North American region is expected to show significant growth over the forecast period.

Vascular Graft Market Competitor Analysis

The vascular graft market is fairly competitive and consists of several major players. Most of these major players enjoy a global presence, and they are facing intense competition in emerging economies. Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic plc, Terumo Medical Corporation, and W.L. Gore & Associates Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Lifestyle-related Disorders
    • 4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 High Risk Associated with Graft Failures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Hemodialysis Access Graft
    • 5.1.2 Endovascular Stent Graft
    • 5.1.3 Peripheral Vascular Graft
    • 5.1.4 Coronary Artery By-pass Graft
  • 5.2 By Application
    • 5.2.1 Aneurysms
    • 5.2.2 Kidney Failure
    • 5.2.3 Vascular Occlusion
    • 5.2.4 Coronary Artery Diseases
    • 5.2.5 Other Applications
  • 5.3 By Raw Material
    • 5.3.1 Synthetic Raw Material
    • 5.3.2 Biological Raw Material
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
    • 6.1.4 Cardinal Health (Cordis Corporation)
    • 6.1.5 Cook Medical
    • 6.1.6 Cryolife
    • 6.1.7 Getinge Group
    • 6.1.8 LeMaitre Vascular Inc
    • 6.1.9 Medtronic PLC
    • 6.1.10 Terumo Medical Corporation
    • 6.1.11 W.L. Gore & Associates Inc
    • 6.1.12 Endologix Inc.
    • 6.1.13 Vascular Graft Solution Ltd.
    • 6.1.14 OrbusNeich

7 MARKET OPPORTUNITIES AND FUTURE TRENDS